Project Scope

Evaluating the value drivers and pricing potential for two pediatric PCV vaccines, and understanding likelihood of achieving access via public funding in both the Kingdom of Saudi Arabia and in South Africa

Challenge

Our client, a leading infectious disease vaccine manufacturer, sought to understand the current recommendation process for adult pneumococcal vaccines in key markets, identify unmet needs, assess payer and VTC value perceptions, pricing potential and applicable funding pathways for two new PCV-20 vaccines. Additionally, they explored the impact of vaccine launch sequence on the price potential

Solution

Conducted extensive primary research to get detailed insights on:

• Landscape assessment and mapping of contributing factors to the unmet need in the PCV space for the markets in scope
• Assessment of the applicable funding pathways for both PCV vaccines as well as grading the impact of various clinical outcomes on payer/physician willingness to pay
• Value perception and price expectations for the two vaccines in both the private and the public market setting

Results

• Successfully enabled our client to understand considerations that influence the adoption and pricing of PCV vaccines in the public and private market
• Recommended likely price points at which patients would be willing to purchase out of pocket